...
首页> 外文期刊>Journal of Clinical Microbiology >Expression of proteins of Mycobacterium tuberculosis in Escherichia coli and potential of recombinant genes and proteins for development of diagnostic reagents.
【24h】

Expression of proteins of Mycobacterium tuberculosis in Escherichia coli and potential of recombinant genes and proteins for development of diagnostic reagents.

机译:结核分枝杆菌蛋白质在大肠杆菌中的表达以及重组基因和蛋白质在开发诊断试剂方面的潜力。

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Recombinant plasmids containing DNA from Mycobacterium tuberculosis were transformed into Escherichia coli, and three colonies were selected by their reactivity with polyclonal antisera to M. tuberculosis. The three recombinant vectors contained DNA inserts of different sizes flanking a common 4.7-kilobase (kb) sequence. Each recombinant produced 35- and 53-kilodalton proteins (35K and 53K proteins, respectively) which were absent in the control E. coli. In Western blotting experiments, both proteins bound several antisera to M. tuberculosis but not antisera to other commonly isolated mycobacteria. Rabbits immunized with the recombinant 35K protein produced antisera which bound to both the 35K and 53K protein bands, a single 35K protein band present in a culture filtrate of M. tuberculosis, and single protein bands with differing molecular weights in whole-cell homogenates from other Mycobacterium spp. An additional recombinant vector containing a 2.2-kb subclone of the 4.7-kb sequence was constructed and, when used as a probe, demonstrated homology with various fragments of chromosomal digests of selected mycobacteria. Reactivity of this probe to Mycobacterium bovis and M. bovis BCG was indistinguishable from reactivity to M. tuberculosis. Immunoglobulin G reactivity to the 35K antigen was detected in antisera from 8 of 20 persons with active tuberculosis, 4 of 18 persons with leprosy, and none of 14 healthy controls. In contrast, reactivity to various proteins in M. tuberculosis culture filtrate was present in 18 of 20 patients with tuberculosis, 16 to 18 patients with leprosy, and 5 of 14 controls. The production of M. tuberculosis proteins by E. coli circumvents many difficulties encountered in the growth and manipulation of M. tuberculosis and may facilitate the development of better diagnostic and immunizing reagents.
机译:将含有结核分枝杆菌DNA的重组质粒转化到大肠杆菌中,并根据它们与结核分枝杆菌的多克隆抗血清的反应性选择了三个菌落。这三个重组载体包含侧翼于共同的4.7碱基(kb)序列的不同大小的DNA插入片段。每个重组体产生在对照大肠杆菌中不存在的35-和53-千达尔顿蛋白(分别为35K和53K蛋白)。在蛋白质印迹实验中,两种蛋白都将几种抗血清与结核分枝杆菌结合,但不与其他通常分离的分枝杆菌结合。用重组35K蛋白免疫的兔子产生的抗血清与35K和53K蛋白带,结核分枝杆菌培养滤液中存在的单个35K蛋白带以及在其他全细胞匀浆中分子量不同的单个蛋白带结合分枝杆菌属构建了另外一个包含4.7-kb序列的2.2-kb亚克隆的重组载体,当用作探针时,证明与所选分枝杆菌的染色体消化产物的各种片段具有同源性。该探针对牛分枝杆菌和牛分枝杆菌BCG的反应性与对结核分枝杆菌的反应性没有区别。在20例活动性结核患者中有8例,18例麻风患者中有4例在抗血清中检测到对35K抗原的免疫球蛋白G反应性,在14例健康对照者中均未检测到。相比之下,结核分枝杆菌培养滤液中各种蛋白质的反应性存在于20名结核病患者中的18名,麻风病患者16至18名和14名对照中的5名。大肠杆菌生产结核分枝杆菌蛋白避免了在结核分枝杆菌的生长和操作中遇到的许多困难,并可能有助于开发更好的诊断和免疫试剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号